Carbohydrase - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

The carbohydrase market size is projected to be USD 2.02 billion in 2025, USD 2.22 billion in 2026, and reach USD 3.04 billion by 2031, growing at a CAGR of 5.57% from 2026 to 2031. This report is Segmented by Type (Alpha Amylase, Xylanases, Pectinase, Hemicellulase, Disaccharidase, Cellulase, and Others), Form (Liquid, Powder, and Granules), Application (Food and Beverages, Pharmaceuticals, Animal Feed, and More), and Geography (North America, Europe, Asia-Pacific, South America, and Middle East and Africa). The Market Forecasts are Provided in Terms of Value (USD).

Global Carbohydrase Market Trends and Insights

Growing Demand for Processed and Convenience Foods

The Carbohydrase market is closely tied to processed food demand because packaged and shelf-stable products require more precise texture control, flavor stability, and shelf-life management. The Carbohydrase market also gains from the continued rise in cereal processing, since starch conversion remains a core step in glucose syrup, sweetener, and related production chains. Global cereal grain output has remained above 2.8 billion tonnes in recent years, providing a large and steady base for starch-processing enzymes such as alpha-amylase and glucoamylase . Processed dairy is adding another layer of demand, especially where lactose-reduced and probiotic-oriented products require more precise enzymatic handling during reformulation. The Carbohydrase market still has room to deepen in Asia-Pacific and Latin America, where food processing systems are formalizing, and enzyme intensity remains below North American and European levels. Large manufacturers are also using optimized enzyme blends to ease input-cost pressure without weakening product quality, which strengthens the economic case for broader adoption.

Expansion of the Bakery Industry

The Carbohydrase market has a strong link to bakery production because alpha-amylase and xylanase remain basic processing tools for dough conditioning, loaf volume improvement, and anti-staling performance. The Carbohydrase market is therefore supported whenever industrial bakeries add capacity or replace chemical improvers with cleaner processing systems. A 2025 review in Foods showed that protein-engineered alpha-amylases are improving thermostability, catalytic efficiency, and reuse potential across bakery and sugar-refining applications. That change matters in North America and Europe, where clean-label reformulation has pushed enzyme blends into roles once held by emulsifiers and chemical dough conditioners. Advanced Enzyme Technologies identified baking solutions as a priority growth area in its FY26 presentation and linked that plan to expansion across Europe, the Americas, and other international markets. The Carbohydrase market also has a longer runway in countries such as India and Vietnam, where industrial bakery capacity is rising, and enzyme penetration is still developing.

High Production and Development Costs

The Carbohydrase market remains cost-sensitive because commercial fermentation needs controlled bioreactors, sterile operations, and continuous downstream purification. The Carbohydrase market is also affected by the high share of substrate inputs in operating costs, since glucose syrups, nitrogen sources, and mineral salts can represent 40% to 60% of production expense. That structure favors large manufacturers with fermentation capacity above the scale where unit costs become more competitive with leading market prices. Development costs add another burden because new enzyme preparations require application testing, safety work, and commercial validation before they can earn a place in regulated end uses. Pharmaceutical and digestive supplement channels raise the bar further, since those applications need stronger quality systems than standard food-grade output. The result is a narrower field in higher-value niches, where only a limited group of vertically integrated suppliers can support both compliance and scale.

Other drivers and restraints analyzed in the detailed report include:

• Increasing Adoption in Animal Feed Applications
• Technological Advancements in Enzyme Engineering
• Stringent Regulatory Requirements

Segment Analysis

Alpha Amylase held 48.28% of the carbohydrase market share in 2025, reflecting its central role in starch liquefaction across bakery, brewing, glucose-syrup production, and biofuel feedstock processing. The Carbohydrase market continues to lean on this enzyme type because those end uses sit at the core of global food and industrial carbohydrate conversion. A 2025 review in Foods described how directed evolution, semi-rational design, and immobilization methods are improving alpha-amylase stability and efficiency in food processing. A 2024 review published through PMC showed that xylanase reduces arabinoxylan viscosity in poultry diets and also supports juice clarification, which explains its broad commercial relevance. Pectinase kept its place through juice clarification and wine processing, with adoption growing in fruit-processing markets across Asia and South America. Hemicellulase also gained importance in multi-enzyme bakery blends where it works with alpha-amylase and xylanase to improve dough behavior and crumb structure. Disaccharidase preparations, including lactase and sucrase, added relevance in dairy and confectionery processing as lactose-free and specialized nutrition formats expanded. The broader Carbohydrase market therefore remains anchored by high-volume starch enzymes, but it is steadily diversifying into more application-specific portfolios. That shift makes the type mix more balanced over time without weakening alpha-amylase’s lead position.

Cellulase was the fastest-growing type through 2031, recording a CAGR of 6.73%. The Carbohydrase market is drawing more cellulase demand from renewable fuels because lignocellulosic feedstocks need effective saccharification before conversion. The U.S. Energy Information Administration reported in 2024 that U.S. biofuel production capacity rose by 7% to nearly 24 billion gallons per year, which supports the need for biomass-conversion enzymes. In digestive health, cellulase-containing formulations are appearing more often in over-the-counter enzyme products, where value per unit is higher than in bulk industrial use. This gives the Carbohydrase industry another path to growth beyond large-volume food conversion. It also means that future type expansion will depend not only on scale, but also on how well suppliers can meet different quality and application standards. The Carbohydrase market is therefore seeing faster growth in types that connect industrial processing with health-oriented end uses.

Complete Report Scope:

• By Type
  • Alpha Amalyse
  • Xylanases
  • Pectinase
  • Hemicellulase
  • Cellulase
  • Disaccharidase
  • Others
• By Form
  • Liquid
  • Powder
  • Granuels
• By Application
  • Food and Beverages
  • Pharmaceuticals
  • Animal Feed
  • Bifuel and Biorefinaries
  • Others
• By Geography
  • North America
    • United States
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
    • Netherlands
    • Sweden
    • Poland
    • Belgium
    • Rest of Europe
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Vietnam
    • Indonesia
    • Thailand
    • Singapore
    • Rest of Asia-Pacific
  • South America
    • Brazil
    • Argentina
    • Chile
    • Peru
    • Colombia
    • Rest of South America
  • Middle East and Africa
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Nigeria
    • Egypt
    • Morocco
    • Turkey
    • Rest of Middle East and Africa

Geography Analysis

North America held 38.42% of the carbohydrase market share in 2025. The Carbohydrase market in North America is supported by a large industrial bakery base, a mature starch-sweetener sector, and an FDA GRAS framework that gives suppliers a workable path for novel enzyme commercialization. Recent FDA closures for AB Enzymes’ fructanase preparation in March 2025 and BASF’s beta-mannanase notice for swine feed in July 2025 show that the region is still active in product approvals. The Carbohydrase market also benefits from close working links between enzyme manufacturers and large food producers, which helps speed commercial deployment after approval. South America remained smaller in revenue, but the market pointed to stronger biofuel-linked demand through Brazil’s renewable fuel push and to growing food-processing investment in Chile, Colombia, and Peru. That combination gives the Carbohydrase market in South America a useful mix of fuel, beverage, fruit-processing, and animal nutrition demand. Even so, enzyme intensity per person still trails North America, which leaves room for future adoption gains as local processing scales up.

Europe remained a core revenue region in the Carbohydrase market, but its pace is shaped by strict authorization rules and long review timelines. The Carbohydrase market in Europe therefore rewards suppliers that can sustain larger regulatory investments over several years. The region also benefits from policy support for bio-based production and for lower reliance on chemical food additives, which strengthens the case for enzyme alternatives in bakery, juice, and dairy processing. Advanced Enzyme Technologies reported 15 EFSA filings by early 2026, with 9 positive R&D opinions, which highlights the level of commitment required to stay active in Europe. The Carbohydrase market in smaller European countries such as Poland and Belgium is also moving forward as bakery and flour-milling systems modernize. This means Europe remains important not because it is easy to enter, but because it sets high standards that can favor established and technically capable suppliers.

Asia-Pacific is projected to expand at 6.65% CAGR through 2031, making it the fastest-growing regional block in the Carbohydrase market size outlook. The Carbohydrase market in this region is being driven by rapid industrialization of food and feed supply chains in China, India, Vietnam, and wider Southeast Asia. It also noted that Advanced Enzyme Technologies recorded a 22% year-on-year rise in Animal Nutrition revenue and a 16% increase in food bio-processing revenue in Q3 FY26, reflecting stronger demand across South Asian markets. The Carbohydrase market in the Middle East and Africa remained the smallest by revenue, yet food-processing investment in the UAE, Saudi Arabia, and South Africa is creating a broader base for starch and bakery enzymes. North African countries such as Morocco and Egypt were described as early-stage adopters, with growth linked to flour-milling expansion and local processing by international food manufacturers. This leaves the Carbohydrase market with its fastest growth profile in Asia-Pacific, while the Middle East and Africa develops from a smaller base through capacity-building in food manufacturing.

List of Companies Covered in this Report:

• Novonesis A/S
• BASF SE
• International Flavors and Fragrances Inc.
• AB Enzymes GmbH
• Advanced Enzyme Technologies Limited
• Amano Enzyme Inc.
• Archer Daniels Midland Company
• Biocatalysts Ltd.
• Biocon Limited
• BBI Solutions
• Chr. Hansen Holding A/S
• Creative Enzymes
• DuPont de Nemours, Inc.
• Enzyme Development Corporation
• Kerry Group plc
• Megazyme Ltd.
• Specialty Enzymes and Probiotics
• SUNSON Industry Group Co. Ltd.
• Tex Biosciences (P) Ltd.
• VTR Biotech Pty Limited

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support